1Francine Durocher. Spectrum of Mutations in BRC41、 BRCA2,CHEK2 and TP 53 in Families at High Risk of Breast Caner[J].Journal of the American Medical Association,2006.22-29. 被引量：1
3Parija S,Kumar A. A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer[J].int J Bioinform Res Appl,2011,(01):1-14. 被引量：1
4Yarden RI,Friedman E,Metsuyanim S. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descant[J].Molecular Carcinogenesis,2010,(06):545-555. 被引量：1
5Norberg T,Klaar S,Karf G. Increased P53 mutation frequency during tumor progression-results from a breast cancer cohort[J].Cancer Research,2001,(22):8317-8321. 被引量：1
6Eitan Friedman,Joanne Kotsopulos,Jan Lubinski. Spontaneous and therapeutic abortions and the risk of breast cancer among BR-CA1 mutation carriers[J].Breast Cancer Research,2005,(08):1186-1196. 被引量：1
6Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2 1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet, 2002, 31 (5) : 55-59. 被引量：1
7Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med, 2003, 348 (23) :2339-2347. 被引量：1
8Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med, 2004, 10(8) :789-799. 被引量：1
9Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci, 2004, 95( 11 ) :866-871. 被引量：1
10Horwitz AA, Affarel B, Heine GF, et al. A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase. Proe Natl Acad Sci U S A, 2007, 104(16) :6614-6619. 被引量：1
4MIKI Y, SWENSEN J, SHArI'FULK-EIDENS D. et al. Astrony candidate for the breast cancer and ovarion cancer susceptibility gene BRCAI[J]. Science, 1994, 266: 66-71. 被引量：1
5MILNE R L, ANTONIOU A C. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers[J]. Ann Oncol, 2011, 22 ( Suppl 1): 11-17. 被引量：1
6Yarden RI,Friedman E,Metsuyanim S,et al.Single nucleotide polymorphisms in thd p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish Ashkenazi descant[J].Mol Carcinog,2010,49(6):545-555. 被引量：1
7Lynch HT,Lynch PM,Albano WA,et al.Hereditary cancer:ascertainment and management[J].CA Cancer J Clin,1979,29(4):216-232. 被引量：1
8Phipps RF,Perry PM.Familial breast cancer[J].Postgrad Med J,1988,64(757):847-849. 被引量：1
9Fukutomi T.Hereditary/familial breast cancer[J].Nihon Rinsho,2007,65(Suppl 6):245-248. 被引量：1
10Vogel VG,Costantino JP,Wickerham DL,et al.Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene(STAR)P-2 Trial:Preventing breast cancer[J].Cancer Prev Res(Phila),2010,3(6):696-706. 被引量：1
